PROTAGONIST THERAPEUTICS INC
PTGX · NASDAQ
更新于 2026-10-14 11:07:53
$138.49-4.41%
- 今日最高
- $146.00
- 今日最低
- $137.81
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K线图趋势，实际资料以交易页为准
关键数据
- 昨日开盘价
- $145.83
- 昨日收盘价
- $144.88
- 成交量
- 89.85万
- 市值
- $93.74亿
- 本益比（P/E）
- 113.06X
- 每股收益（EPS）
- $1.03
昨日价格区间
$143.69$152.18
52周价格区间
$65.56$160.81
公司概况
- 板块
- 医疗保健
- 行业
- 生物技术
- 子行业
- 生物技术
- 总部
- 7707 GATEWAY BOULEVARD, NEWARK, CA, UNITED STATES, 94560
- 国家
- 美国
- 上市日期
- 2016-08-11
- 财年截止
- 十二月
- 流通股数
- 6431万
- CIK
- 0001377121
Protagonist Therapeutics, Inc. 是一家临床阶段生物制药公司，致力于发现和开发基于多肽的治疗药物，以满足未被满足的医疗需求。公司总部位于加利福尼亚州纽瓦克。
财务指标
营业收入
2026-06-30
$2.13亿
2026-03-31
$5636.8万
2025-12-31
$743.7万
2025-09-30
$471.2万
营业支出
2026-06-30
$5470.9万
2026-03-31
$5960.9万
2025-12-31
$5779.2万
2025-09-30
$5113.3万
净利润
2026-06-30
$1.62亿
2026-03-31
$378.3万
2025-12-31
-$4438.4万
2025-09-30
-$3933.9万
净利润率
2026-06-30
76.28%
2026-03-31
6.71%
2025-12-31
-596.8%
2025-09-30
-834.86%
每股收益
2026-06-30
$2.29
2026-03-31
$0.05
2025-12-31
$-0.69
2025-09-30
$-0.62
息税折旧摊销前利润
2026-06-30
$1.65亿
2026-03-31
$268.8万
2025-12-31
-$4334.2万
2025-09-30
-$3897.8万
有效税率
2026-06-30
1.37%
2026-03-31
-65.84%
2025-12-31
-1.52%
2025-09-30
--
| 项目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 营业收入 | $2.13亿 | $5636.8万 | $743.7万 | $471.2万 |
| 营业支出 | $5470.9万 | $5960.9万 | $5779.2万 | $5113.3万 |
| 净利润 | $1.62亿 | $378.3万 | -$4438.4万 | -$3933.9万 |
| 净利润率 | 76.28% | 6.71% | -596.8% | -834.86% |
| 每股收益 | $2.29 | $0.05 | $-0.69 | $-0.62 |
| 息税折旧摊销前利润 | $1.65亿 | $268.8万 | -$4334.2万 | -$3897.8万 |
| 有效税率 | 1.37% | -65.84% | -1.52% | -- |
常见问题
风险提示
股价可能大幅波动，短时间内可能出现显著涨跌。 数字资产与衍生品交易可能涉及杠杆、流动性等额外风险。 本页内容仅供参考，不构成任何投资建议。 产品可用性与访问可能因地区及适用法规而异。